Xeltis is Trialing its Polymer-based Vascular Access

aXess is a self-healing device that allows the patient’s cells to colonize a polymeric matrix which then becomes an access. A U.S. trial has started enrolling patients. The FDA granted Xeltis Breakthrough Device Designation status.

Read the full article » | Posted 03-12-2026

Related Articles